Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 642 entries
Sorted by: Best Match Show Resources per page
Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways.

BMC cancer

Wang Y, Nie H, Zhao X, Qin Y, Gong X.
PMID: 27654866
BMC Cancer. 2016 Sep 21;16(1):742. doi: 10.1186/s12885-016-2767-2.

BACKGROUND: Bicyclol, a novel synthetic antihepatitis drug, is widely known to protect against liver injury. However, few reports have focused on the possible effect of bicyclol on anti-proliferation and autophagy induction in cancer cells, particularly hepatocellular carcinoma cells.METHODS: In...

Cite
Wang Y, Nie H, Zhao X, et al. Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways. BMC Cancer. 2016;16(1):742doi: 10.1186/s12885-016-2767-2.
Wang, Y., Nie, H., Zhao, X., Qin, Y., & Gong, X. (2016). Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways. BMC cancer, 16(1), 742. https://doi.org/10.1186/s12885-016-2767-2
Wang, Yu, et al. "Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways." BMC cancer vol. 16,1 (2016): 742. doi: https://doi.org/10.1186/s12885-016-2767-2
Wang Y, Nie H, Zhao X, Qin Y, Gong X. Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways. BMC Cancer. 2016 Sep 21;16(1):742. doi: 10.1186/s12885-016-2767-2. PMID: 27654866; PMCID: PMC5031284.
Copy Download .nbib Format: NLM
Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study.

BMC cancer

Nakamura H, Yano T, Fujii S, Kadota T, Tomioka T, Shinozaki T, Hayashi R, Kaneko K.
PMID: 27654955
BMC Cancer. 2016 Sep 21;16(1):743. doi: 10.1186/s12885-016-2787-y.

BACKGROUND: The incidence rate has been increasing for superficial head and neck squamous cell carcinoma (HNSCC) discovered through surveillance endoscopic study using narrow band imaging (NBI), a procedure mainly used for high-risk patients with esophageal squamous cell carcinoma (ESCC)....

Cite
Nakamura H, Yano T, Fujii S, et al. Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study. BMC Cancer. 2016;16(1):743doi: 10.1186/s12885-016-2787-y.
Nakamura, H., Yano, T., Fujii, S., Kadota, T., Tomioka, T., Shinozaki, T., Hayashi, R., & Kaneko, K. (2016). Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study. BMC cancer, 16(1), 743. https://doi.org/10.1186/s12885-016-2787-y
Nakamura, Hiroshi, et al. "Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study." BMC cancer vol. 16,1 (2016): 743. doi: https://doi.org/10.1186/s12885-016-2787-y
Nakamura H, Yano T, Fujii S, Kadota T, Tomioka T, Shinozaki T, Hayashi R, Kaneko K. Natural history of superficial head and neck squamous cell carcinoma under scheduled follow-up endoscopic observation with narrow band imaging: retrospective cohort study. BMC Cancer. 2016 Sep 21;16(1):743. doi: 10.1186/s12885-016-2787-y. PMID: 27654955; PMCID: PMC5031266.
Copy Download .nbib Format: NLM
Erratum to: gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol.

BMC cancer

Oude Ophuis CMC, Koppert LB, de Monyé C, van Deurzen CHM, Koljenović S, van Akkooi ACJ, Verhoef C, Grünhagen DJ.
PMID: 28558666
BMC Cancer. 2017 May 30;17(1):387. doi: 10.1186/s12885-017-3363-9.

No abstract available.

Cite
Oude Ophuis CMC, Koppert LB, de Monyé C, et al. Erratum to: gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol. BMC Cancer. 2017;17(1):387doi: 10.1186/s12885-017-3363-9.
Oude Ophuis, C. M. C., Koppert, L. B., de Monyé, C., van Deurzen, C. H. M., Koljenović, S., van Akkooi, A. C. J., Verhoef, C., & Grünhagen, D. J. (2017). Erratum to: gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol. BMC cancer, 17(1), 387. https://doi.org/10.1186/s12885-017-3363-9
Oude Ophuis, Charlotte M C, et al. "Erratum to: gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol." BMC cancer vol. 17,1 (2017): 387. doi: https://doi.org/10.1186/s12885-017-3363-9
Oude Ophuis CMC, Koppert LB, de Monyé C, van Deurzen CHM, Koljenović S, van Akkooi ACJ, Verhoef C, Grünhagen DJ. Erratum to: gamma probe and ultrasound guided fine needle aspiration cytology of the sentinel node (GULF) trial - overview of the literature, pilot and study protocol. BMC Cancer. 2017 May 30;17(1):387. doi: 10.1186/s12885-017-3363-9. PMID: 28558666; PMCID: PMC5450197.
Copy Download .nbib Format: NLM
Prospective study of postoperative whole breast radiotherapy for Japanese large-breasted women: a clinical and dosimetric comparisons between supine and prone positions and a dose measurement using a breast phantom.

BMC cancer

Takahashi K, Morota M, Kagami Y, Okamoto H, Sekii S, Inaba K, Murakami N, Igaki H, Ito Y, Uno T, Itami J.
PMID: 27681376
BMC Cancer. 2016 Sep 29;16(1):757. doi: 10.1186/s12885-016-2794-z.

BACKGROUND: This prospective study aimed to compare dose volume histograms (DVH) of the breasts and organs at risk (OARs) of whole breast radiotherapy in the supine and prone positions, and frequency and severity of acute and late toxicities were...

Cite
Takahashi K, Morota M, Kagami Y, et al. Prospective study of postoperative whole breast radiotherapy for Japanese large-breasted women: a clinical and dosimetric comparisons between supine and prone positions and a dose measurement using a breast phantom. BMC Cancer. 2016;16(1):757doi: 10.1186/s12885-016-2794-z.
Takahashi, K., Morota, M., Kagami, Y., Okamoto, H., Sekii, S., Inaba, K., Murakami, N., Igaki, H., Ito, Y., Uno, T., & Itami, J. (2016). Prospective study of postoperative whole breast radiotherapy for Japanese large-breasted women: a clinical and dosimetric comparisons between supine and prone positions and a dose measurement using a breast phantom. BMC cancer, 16(1), 757. https://doi.org/10.1186/s12885-016-2794-z
Takahashi, Kana, et al. "Prospective study of postoperative whole breast radiotherapy for Japanese large-breasted women: a clinical and dosimetric comparisons between supine and prone positions and a dose measurement using a breast phantom." BMC cancer vol. 16,1 (2016): 757. doi: https://doi.org/10.1186/s12885-016-2794-z
Takahashi K, Morota M, Kagami Y, Okamoto H, Sekii S, Inaba K, Murakami N, Igaki H, Ito Y, Uno T, Itami J. Prospective study of postoperative whole breast radiotherapy for Japanese large-breasted women: a clinical and dosimetric comparisons between supine and prone positions and a dose measurement using a breast phantom. BMC Cancer. 2016 Sep 29;16(1):757. doi: 10.1186/s12885-016-2794-z. PMID: 27681376; PMCID: PMC5041564.
Copy Download .nbib Format: NLM
Erratum to: Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice.

BMC cancer

Hens JR, Sinha I, Perodin F, Cooper T, Sinha R, Plummer J, Perrone CE, Orentreich D.
PMID: 27417544
BMC Cancer. 2016 Jul 14;16(1):474. doi: 10.1186/s12885-016-2404-0.

No abstract available.

Cite
Hens JR, Sinha I, Perodin F, et al. Erratum to: Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice. BMC Cancer. 2016;16(1):474doi: 10.1186/s12885-016-2404-0.
Hens, J. R., Sinha, I., Perodin, F., Cooper, T., Sinha, R., Plummer, J., Perrone, C. E., & Orentreich, D. (2016). Erratum to: Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice. BMC cancer, 16(1), 474. https://doi.org/10.1186/s12885-016-2404-0
Hens, J R, et al. "Erratum to: Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice." BMC cancer vol. 16,1 (2016): 474. doi: https://doi.org/10.1186/s12885-016-2404-0
Hens JR, Sinha I, Perodin F, Cooper T, Sinha R, Plummer J, Perrone CE, Orentreich D. Erratum to: Methionine-restricted diet inhibits growth of MCF10AT1-derived mammary tumors by increasing cell cycle inhibitors in athymic nude mice. BMC Cancer. 2016 Jul 14;16(1):474. doi: 10.1186/s12885-016-2404-0. PMID: 27417544; PMCID: PMC4944442.
Copy Download .nbib Format: NLM
Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells.

BMC cancer

Xu XD, Yang L, Zheng LY, Pan YY, Cao ZF, Zhang ZQ, Zhou QS, Yang B, Cao C.
PMID: 27377267
BMC Cancer. 2016 Jul 04;16(1):374. doi: 10.1186/s12885-016-2401-3.

No abstract available.

Cite
Xu XD, Yang L, Zheng LY, et al. Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC Cancer. 2016;16(1):374doi: 10.1186/s12885-016-2401-3.
Xu, X. D., Yang, L., Zheng, L. Y., Pan, Y. Y., Cao, Z. F., Zhang, Z. Q., Zhou, Q. S., Yang, B., & Cao, C. (2016). Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC cancer, 16(1), 374. https://doi.org/10.1186/s12885-016-2401-3
Xu, Xing-Dong, et al. "Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells." BMC cancer vol. 16,1 (2016): 374. doi: https://doi.org/10.1186/s12885-016-2401-3
Xu XD, Yang L, Zheng LY, Pan YY, Cao ZF, Zhang ZQ, Zhou QS, Yang B, Cao C. Erratum to: Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells. BMC Cancer. 2016 Jul 04;16(1):374. doi: 10.1186/s12885-016-2401-3. PMID: 27377267; PMCID: PMC4932722.
Copy Download .nbib Format: NLM
Erratum to: Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer.

BMC cancer

Pak KH, Kim DH, Kim H, Lee DH, Cheong JH.
PMID: 26879369
BMC Cancer. 2016 Feb 15;16:99. doi: 10.1186/s12885-016-2140-5.

No abstract available.

Cite
Pak KH, Kim DH, Kim H, et al. Erratum to: Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer. BMC Cancer. 2016;16:99doi: 10.1186/s12885-016-2140-5.
Pak, K. H., Kim, D. H., Kim, H., Lee, D. H., & Cheong, J. H. (2016). Erratum to: Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer. BMC cancer, 1699. https://doi.org/10.1186/s12885-016-2140-5
Pak, Kyung Ho, et al. "Erratum to: Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer." BMC cancer vol. 16 (2016): 99. doi: https://doi.org/10.1186/s12885-016-2140-5
Pak KH, Kim DH, Kim H, Lee DH, Cheong JH. Erratum to: Differences in TGF-β1 signaling and clinicopathologic characteristics of histologic subtypes of gastric cancer. BMC Cancer. 2016 Feb 15;16:99. doi: 10.1186/s12885-016-2140-5. PMID: 26879369; PMCID: PMC4753667.
Copy Download .nbib Format: NLM
BMC Obesity - expanding the BMC series into an important area of research.

BMC obesity

Horne G, McTernan P, Visscher T, Peeters A.
PMID: 26217494
BMC Obes. 2014 Feb 19;1:1. doi: 10.1186/2052-9538-1-1. eCollection 2014.

This Editorial marks the launch of an important new journal to join the BMC series portfolio - BMC Obesity. BMC Obesity joins BMC Cancer as the second journal within the series to focus on a particular condition in the...

Cite
Horne G, McTernan P, Visscher T, et al. BMC Obesity - expanding the BMC series into an important area of research. BMC Obes. 2014;1:1doi: 10.1186/2052-9538-1-1.
Horne, G., McTernan, P., Visscher, T., & Peeters, A. (2014). BMC Obesity - expanding the BMC series into an important area of research. BMC obesity, 11. https://doi.org/10.1186/2052-9538-1-1
Horne, Genevieve, et al. "BMC Obesity - expanding the BMC series into an important area of research." BMC obesity vol. 1 (2014): 1. doi: https://doi.org/10.1186/2052-9538-1-1
Horne G, McTernan P, Visscher T, Peeters A. BMC Obesity - expanding the BMC series into an important area of research. BMC Obes. 2014 Feb 19;1:1. doi: 10.1186/2052-9538-1-1. eCollection 2014. PMID: 26217494; PMCID: PMC4472621.
Copy Download .nbib Format: NLM
The structure and demographic correlates of cancer fear.

BMC cancer

Vrinten C, van Jaarsveld CH, Waller J, von Wagner C, Wardle J.
PMID: 25129323
BMC Cancer. 2014 Aug 16;14:597. doi: 10.1186/1471-2407-14-597.

BACKGROUND: Cancer is often described as the 'number one' health fear, but little is known about whether this affects quality of life by translating into high levels of worry or distress in everyday life, or which population groups are...

Cite
Vrinten C, van Jaarsveld CH, Waller J, et al. The structure and demographic correlates of cancer fear. BMC Cancer. 2014;14:597doi: 10.1186/1471-2407-14-597.
Vrinten, C., van Jaarsveld, C. H., Waller, J., von Wagner, C., & Wardle, J. (2014). The structure and demographic correlates of cancer fear. BMC cancer, 14597. https://doi.org/10.1186/1471-2407-14-597
Vrinten, Charlotte, et al. "The structure and demographic correlates of cancer fear." BMC cancer vol. 14 (2014): 597. doi: https://doi.org/10.1186/1471-2407-14-597
Vrinten C, van Jaarsveld CH, Waller J, von Wagner C, Wardle J. The structure and demographic correlates of cancer fear. BMC Cancer. 2014 Aug 16;14:597. doi: 10.1186/1471-2407-14-597. PMID: 25129323; PMCID: PMC4148526.
Copy Download .nbib Format: NLM
Correction to: Sepsis increases perioperative metastases in a murine model.

BMC cancer

Tai LH, Ananth AA, Seth R, Alkayyal A, Zhang J, de Souza CT, Staibano P, Kennedy MA, Auer RC.
PMID: 29665786
BMC Cancer. 2018 Apr 17;18(1):437. doi: 10.1186/s12885-018-4248-2.

It has been highlighted that the original manuscript [1] contains a typesetting error in Fig. 1 and the Fig. 1c panel gas been inadvertently duplicated in panel Fig. 1d. This does not affect the results and conclusions of the...

Cite
Tai LH, Ananth AA, Seth R, et al. Correction to: Sepsis increases perioperative metastases in a murine model. BMC Cancer. 2018;18(1):437doi: 10.1186/s12885-018-4248-2.
Tai, L. H., Ananth, A. A., Seth, R., Alkayyal, A., Zhang, J., de Souza, C. T., Staibano, P., Kennedy, M. A., & Auer, R. C. (2018). Correction to: Sepsis increases perioperative metastases in a murine model. BMC cancer, 18(1), 437. https://doi.org/10.1186/s12885-018-4248-2
Tai, Lee-Hwa, et al. "Correction to: Sepsis increases perioperative metastases in a murine model." BMC cancer vol. 18,1 (2018): 437. doi: https://doi.org/10.1186/s12885-018-4248-2
Tai LH, Ananth AA, Seth R, Alkayyal A, Zhang J, de Souza CT, Staibano P, Kennedy MA, Auer RC. Correction to: Sepsis increases perioperative metastases in a murine model. BMC Cancer. 2018 Apr 17;18(1):437. doi: 10.1186/s12885-018-4248-2. PMID: 29665786; PMCID: PMC5905137.
Copy Download .nbib Format: NLM
Correction to: Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.

BMC cancer

Marcq G, Michelet A, Hannink G, Rizk J, Sauvain J, Villers A, Saffarini M, Rochat CH.
PMID: 30732574
BMC Cancer. 2019 Feb 07;19(1):124. doi: 10.1186/s12885-019-5296-y.

Following publication of the original article [1], we have been notified that the authors' last names have been incorrectly tagged as first names and vice-versa. The original publication has been corrected.

Cite
Marcq G, Michelet A, Hannink G, et al. Correction to: Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy. BMC Cancer. 2019;19(1):124doi: 10.1186/s12885-019-5296-y.
Marcq, G., Michelet, A., Hannink, G., Rizk, J., Sauvain, J., Villers, A., Saffarini, M., & Rochat, C. H. (2019). Correction to: Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy. BMC cancer, 19(1), 124. https://doi.org/10.1186/s12885-019-5296-y
Marcq, Gautier, et al. "Correction to: Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy." BMC cancer vol. 19,1 (2019): 124. doi: https://doi.org/10.1186/s12885-019-5296-y
Marcq G, Michelet A, Hannink G, Rizk J, Sauvain J, Villers A, Saffarini M, Rochat CH. Correction to: Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy. BMC Cancer. 2019 Feb 07;19(1):124. doi: 10.1186/s12885-019-5296-y. PMID: 30732574; PMCID: PMC6366108.
Copy Download .nbib Format: NLM
Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options.

BMC cancer

McAnena PF, McGuire A, Ramli A, Curran C, Malone C, McLaughlin R, Barry K, Brown JAL, Kerin MJ.
PMID: 29463223
BMC Cancer. 2018 Feb 20;18(1):203. doi: 10.1186/s12885-018-4101-7.

BACKGROUND: Recent studies have shown that breast cancer subtype can change from the primary tumour to the recurrence. Discordance between primary and recurrent breast cancer has implications for further treatment and ultimately prognosis. The aim of the study was...

Cite
McAnena PF, McGuire A, Ramli A, et al. Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options. BMC Cancer. 2018;18(1):203doi: 10.1186/s12885-018-4101-7.
McAnena, P. F., McGuire, A., Ramli, A., Curran, C., Malone, C., McLaughlin, R., Barry, K., Brown, J. A. L., & Kerin, M. J. (2018). Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options. BMC cancer, 18(1), 203. https://doi.org/10.1186/s12885-018-4101-7
McAnena, Peter F, et al. "Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options." BMC cancer vol. 18,1 (2018): 203. doi: https://doi.org/10.1186/s12885-018-4101-7
McAnena PF, McGuire A, Ramli A, Curran C, Malone C, McLaughlin R, Barry K, Brown JAL, Kerin MJ. Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options. BMC Cancer. 2018 Feb 20;18(1):203. doi: 10.1186/s12885-018-4101-7. PMID: 29463223; PMCID: PMC5819681.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 642 entries